Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.tarsons.com | |
Market Cap | 2,465.85 Cr. | |
Enterprise Value(EV) | 2,602.30 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 11.53 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 40.20 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 49.39 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 111.11 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 4.17 | Calculated using Price: 463.45 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.32 Cr. | 53,206,281 Shares |
FaceValue | 2 | |
About Tarsons Products Ltd. | ||
Tarsons Products is an Indian labware company engaged in the designing, development, manufacturing and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (CROs), Diagnostic companies and hospitals. It manufactures a range of quality labware products which helps advance scientific discovery and improve healthcare. The company’s product portfolio is classified into three key categories which include consumables, reusables, and others. ‘Consumables’ category includes products such as centrifuge ware, cryogenic ware, liquid handling, PCR consumables and petri dish, transfer pipettes and others. ‘Reusables’ category includes products such as bottles, carboys, beakers, measuring cylinders and tube racks. ‘Others’ category includes benchtop instrumentation such as vortex shakers, centrifuges pipettors and others. |
1 Day |
|
+0.06% |
1 Week |
|
+2.73% |
1 Month |
|
-3.29% |
3 Month |
|
-12.75% |
6 Month |
|
-19.08% |
1 Year |
|
-36.24% |
2 Year |
|
-23.82% |
5 Year |
|
|
10 Year |
|
5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 28.80 | 24.35 | 31.17 | 27.42 | 15.24 | |
Return on Capital Employed (%) | 31.57 | 27.35 | 37.22 | 35.28 | 19.00 | |
Return on Assets (%) | 18.38 | 17.60 | 21.51 | 18.90 | 10.40 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 135 | 198 | 244 | 490 | 569 | 591 | |
Non Curr. Liab. | 23 | 11 | 106 | 149 | 223 | 92 | |
Curr. Liab. | 54 | 40 | 42 | 35 | 88 | 66 | |
Minority Int. | |||||||
Equity & Liab. | 212 | 249 | 392 | 673 | 879 | 749 | |
Non Curr. Assets | 115 | 129 | 279 | 429 | 603 | 544 | |
Curr. Assets | 97 | 120 | 113 | 245 | 277 | 205 | |
Misc. Exp. not W/O | |||||||
Total Assets | 212 | 249 | 392 | 673 | 879 | 749 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 179 | 176 | 229 | 301 | 283 | 272 | |
Other Income | 6 | 5 | 5 | 8 | 12 | 10 | |
Total Income | 185 | 181 | 234 | 309 | 296 | 283 | |
Total Expenditure | -107 | -108 | -125 | -148 | -154 | -160 | |
PBIDT | 78 | 73 | 109 | 161 | 142 | 123 | |
Interest | -7 | -6 | -3 | -4 | -4 | -7 | |
Depreciation | -15 | -14 | -14 | -22 | -29 | -33 | |
Taxation | -17 | -13 | -24 | -34 | -28 | -22 | |
Exceptional Items | |||||||
PAT | 39 | 41 | 69 | 101 | 81 | 61 | |
Adjusted EPS | 14 | 19 | 15 | 12 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 51 | 64 | 68 | 83 | 76 | |
Cash Fr. Inv. | -34 | -25 | -64 | -138 | -179 | |
Cash Fr. Finan. | -18 | -14 | -27 | 130 | 85 | |
Net Change | 0 | 25 | -23 | 75 | -18 | |
Cash & Cash Eqvt | 1 | 25 | 2 | 77 | 59 |
Wed, 22 Nov 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcripts of Earnings Call held on 17th November 2023 |
Fri, 17 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Audio Recording |
Thu, 16 Nov 2023
Announcement Under Regulation 30 Of SEBI LODR Announcement under Regulation 30 of SEBI LODR |
Fri, 08 Dec 2023 |
|
|
|
|
|